The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve

B Whisenant, SR Kapadia, MF Eleid, SK Kodali… - JAMA …, 2020 - jamanetwork.com
Importance Bioprosthetic mitral valves are implanted with increasing frequency but
inevitably degenerate, leading to heart failure. Reoperation is associated with high morbidity …

The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

JM Khan, AB Greenbaum, VC Babaliaros… - JACC: Cardiovascular …, 2019 - jacc.org
Abstract Objectives: The BASILICA (Bioprosthetic or native Aortic Scallop Intentional
Laceration to prevent Iatrogenic Coronary Artery obstruction during TAVR) investigational …

Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native …

M Guerrero, S Vemulapalli, Q Xiang… - Circulation …, 2020 - Am Heart Assoc
Background: Transcatheter mitral valve replacement using aortic transcatheter heart valves
has recently become an alternative for patients with degenerated mitral bioprostheses, failed …

Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from …

M Simonato, B Whisenant, HB Ribeiro, JG Webb… - Circulation, 2021 - Am Heart Assoc
Background: Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical
reoperation in patients with recurrent mitral valve failure after previous surgical valve repair …

[HTML][HTML] The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem

IH Jaffer, JI Weitz - Acta biomaterialia, 2019 - Elsevier
Blood-contacting medical devices are an integral part of modern medicine. Such devices
may be used for only a few hours or may be implanted for life. Despite advances in …

Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement

JM Khan, VC Babaliaros, AB Greenbaum… - Journal of the American …, 2019 - jacc.org
Background: Left ventricular outflow tract (LVOT) obstruction is a leading cause of mortality
and exclusion from transcatheter mitral valve replacement (TMVR). Intentional laceration of …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel

MY Desai, S Windecker, P Lancellotti, JJ Bax… - Journal of the American …, 2019 - jacc.org
Radiation-associated cardiac disease, a heterogeneous and complex disease, manifests
years or even decades following radiation exposure to the chest. It is associated with a …